Announcing Our New Fenway Health Board of Directors Members
Fenway Health is pleased to announce the appointment of four new members to its Board of Directors for fiscal year 2021. Each new member brings a wealth
HPTN 083 Study Demonstrates Superiority of Cabotegravir for the Prevention of HIV
DURHAM, N.C. – Researchers from the HIV Prevention Trials Network (HPTN) announced today that the HPTN 083 clinical trial showed that a pre-exposure prophylaxis (PrEP) regimen
The Fenway Institute’s Douglas Krakower Presents on PrEP and COVID During AIDS 2020: Virtual Conference
The 23rd International AIDS Conference – also known this year as AIDS 2020: Virtual – is underway this week, as researchers, physicians, and advocates around the
A Statement to the Community: #StopHateForProfit
Over the past month, America has begun a long overdue conversation about the legacy of violence and discrimination against our Black community. It’s abundantly clear
Paper calls for new psychiatric practices that affirm transgender and gender-diverse patients without pathologizing diagnoses
BOSTON, June 30, 2020—An editorial published in The British Journal of Psychiatry calls for the development of alternative psychiatric care frameworks that affirm transgender and
Editorial Envisions Future for Transgender Behavioral Health Care
A new editorial in the British Journal of Psychology looks at the current state of psychiatric diagnoses – and the limitations of those diagnoses –
Introducing Our New COVID-19 Study
The Fenway Institute is excited to announce our newest COVID-19 study as part of our continuing efforts to aid in the search for a COVID-19
Register Today For The 2020 Advancing Excellence in Transgender Health Conference
The Fenway Institute is pleased to announce that registration is open for the 2020 Advancing Excellence in Transgender Health Conference. The conference will take place